A comparative study of induced pluripotent stem cells generated from frozen, stocked bone marrow- and adipose tissue-derived mesenchymal stem cells

Journal of Tissue Engineering and Regenerative Medicine

Volumn 6, Issue 4, 2012, Pages 261-271

  Ohnishi, Hiroe ^a   Oda, Yasuaki ^a   Aoki, Tetsuhiro ^a,b   Tadokoro, Mika ^a   Katsube, Yoshihiro ^a   Ohgushi, Hajime ^a   Hattori, Koji ^a   Yuba, Shunsuke ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b SHINSHU UNIVERSITY   (Japan)

Author keywords

Adipose tissue; Bone marrow; Embryonic stem cells; Induced pluripotent stem cells; Mesenchymal stem cells; Regenerative medicine; Somatic stem cells; Tissue engineering

Indexed keywords

ANTIGENS; BONE; CELL ENGINEERING; CELL PROLIFERATION; REGENERATIVE MEDICINE; STEM CELLS; TISSUE REGENERATION;

ADIPOSE TISSUE; ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS; BONE MARROW; EMBRYONIC STEM CELLS; INDUCED PLURIPOTENT STEM CELLS; MESENCHYMAL STEM CELL; REGENERATIVE MEDICINE; SOMATIC STEM CELL; STEM-CELL; TISSUES ENGINEERINGS;

CELL CULTURE;

CELL MARKER; OCTAMER TRANSCRIPTION FACTOR 4; STAGE SPECIFIC EMBRYO ANTIGEN 3; STAGE SPECIFIC EMBRYO ANTIGEN 4; TRANSCRIPTION FACTOR NANOG; TUMOR RELATED ANTIGEN 1 60; TUMOR RELATED ANTIGEN 1 81; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEVELOPMENT; BONE MARROW; CELL DIFFERENTIATION; CELL POPULATION; COMPARATIVE STUDY; CONTROLLED STUDY; GERM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TERATOMA;

EID: 84859425716     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.428     Document Type: Article

References (36)

1. Aoki T, Ohnishi H, Oda Y, et al. 2010; Generation of induced pluripotent stem cells from human adipose-derived stem cells without c-MYC. Tissue Eng A 16: 2197-2206.
2. Ieda M, Fu JD, Delgado-Olguin P, et al. 2010; Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142: 375-386.
3. Fraser JK, Wulur I, Alfonso Z, et al. 2006; Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol 24: 150-154.
4. Fusaki N, Ban H, Nishiyama A, et al. 2009; Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci 85: 348-362.
5. Garcia-Olmo D, Garcia-Arranz M, Garcia LG, et al. 2003; Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn's disease: a new cell-based therapy. Int J Colorectal Dis 18: 451-454.
6. Garcia-Olmo D, Garcia-Arranz M, Herreros D, et al. 2005; A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 48: 1416-1423.
7. Gimble JM, 2003; Adipose tissue-derived therapeutics. Expert Opin Biol Ther 3: 705-713.
8. Gimble JM, Katz AJ, Bunnell BA, et al. 2007; Adipose-derived stem cells for regenerative medicine. Circ Res 100: 1249-1260.
9. Hayashi O, Katsube Y, Hirose M, et al. 2008; Comparison of osteogenic ability of rat mesenchymal stem cells from bone marrow, periosteum, and adipose tissue. Calcif Tissue Int 82: 238-247.
10. Huangfu D, Osafune K, Maehr R, et al. 2008; Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 26: 1269-1275.
11. Kim D, Kim CH, Moon JI, et al. 2009a; Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4: 472-476.
12. Kim JB, Greber B, Arauzo-Bravo MJ, et al. 2009b; Direct reprogramming of human neural stem cells by OCT4. Nature 461: 649-653.
13. Kim JB, Sebastiano V, Wu G, et al. 2009c; Oct4-induced pluripotency in adult neural stem cells. Cell 136: 411-419.
14. Kim JB, Zaehres H, Wu G, et al. 2008; Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 454: 646-650.
15. Kern S, Eichler H, Stoeve J, et al. 2006; Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24: 1294-1301.
16. Kotobuki N, Hirose M, Machida H, et al. 2005; Viability and osteogenic potential of cryopreserved human bone marrow-derived mesenchymal cells. Tissue Eng 11: 663-673.
17. Lendeckel S, Jodicke A, Christophis P, et al. 2004; Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: case report. J Craniomaxillofac Surg 32: 370-373.
18. Li W, Zhou H, Abujarour R, et al. 2009; Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. Stem Cells 27: 2992-3000.
19. Lin T, Ambasudhan R, Yuan X, 2009; A chemical platform for improved induction of human iPSCs. Nat Methods 6: 805-808.
20. Mali P, Chou BK, Yen J, et al. 2010; Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. Stem Cells 28: 713-720.
21. Miura K, Okada Y, Aoi T, et al. 2009; Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol 27: 743-745.
22. Morishita T, Honoki K, Ohgushi H, et al. 2006; Tissue engineering approach to the treatment of bone tumors: three cases of cultured bone grafts derived from patients' mesenchymal stem cells. Artif Organs 30: 115-118.
23. Nakagawa M, Koyanagi M, Tanabe K, et al. 2008; Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26: 101-106.
24. Oda Y, Yoshimura Y, Ohnishi H, et al. 2010; Induction of pluripotent stem cells from human third molar mesenchymal stromal cells. J Biol Chem 285: 29270-29278.
25. Ohgushi H, Caplan AI, 1999; Stem cell technology and bioceramics: from cell to gene engineering. J Biomed Mater Res 48: 913-927.
26. Ohgushi H, Kotobuki N, Funaoka H, et al. 2005; Tissue engineered ceramic artificial joint-ex vivo osteogenic differentiation of patient mesenchymal cells on total ankle joints for treatment of osteoarthritis. Biomaterials 26: 4654-4661.
27. Okita K, Ichisaka T, Yamanaka S, 2007; Generation of germline-competent induced pluripotent stem cells. Nature 448: 313-317.
28. Patel M, Yang S, 2010; Advances in reprogramming somatic cells to induced pluripotent stem cells. Stem Cell Rev 6: 367-380.
29. Salem HK, Thiemermann C, 2009; Mesenchymal stromal cells: current understandingnd clinical status. Stem Cells 28: 585-596.
30. Takahashi K, Tanabe K, Ohnuki M, et al. 2007; Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
31. Takahashi K, Yamanaka S, 2006; Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
32. Vierbuchen T, Ostermeier A, Pang ZP, et al. 2010; Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463: 1035-1041.
33. Wernig M, Meissner A, Cassady JP, et al. 2008; c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2: 10-12.
34. Yoshimura K, Sato K, Aoi N, et al. 2008; Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells. Aesthetic Plast Surg 32: 48-55, discussion 56-57.
35. Yu J, Vodyanik MA, Smuga-Otto K, et al. 2007; Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.
36. Zhou H, Wu S, Joo JY, et al. 2009; Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4: 381-384.